Keyphrases
Administrative Regulation
16%
Antidepressants
16%
Arketamine
16%
Clinical Practice
16%
Clinical Response
16%
Cochrane
16%
Comparative Trial
16%
Depressive Symptoms
16%
Dosage Forms
16%
Duration of Use
16%
Embase
16%
Frequency of Use
16%
Human Studies
16%
Intranasal Ketamine
50%
Ketamine
100%
Literature Search
33%
Major Depressive Disorder
16%
MEDLINE
16%
Narrative Review
100%
Nasal Spray
16%
NewHope
100%
Pharmacology
16%
Phase II Study
33%
Phase II Trial
16%
Product Information
16%
PsycINFO
16%
R-enantiomer
16%
Regulation Cost
16%
Remission
16%
S-enantiomer
16%
Safety Efficacy
16%
Tolerability
16%
Treatment-resistant Depression
100%
United States
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
16%
Depressive Disorder
16%
Dosage Form
16%
Esketamine
100%
Human Study
16%
Ketamine
16%
Major Depression
16%
Nasal Spray
16%
Phase III Trials
16%
Remission
16%
Safety Pharmacology
16%
Tolerability
16%
Treatment Resistant Depression
100%
Nursing and Health Professions
Antidepressant
16%
Clinical Practice
16%
Depressive Disorder
16%
Drug Dosage Form
16%
Embase
16%
Esketamine
100%
Ketamine
16%
Major Depression
16%
Medline
16%
Nasal Spray
16%
PsycINFO
16%
Remission
16%
Treatment Resistant Depression
100%
Neuroscience
Antidepressant
16%
Depressive Disorder
16%
Esketamine
100%
Ketamine
16%
Major Depressive Disorder
16%
Nasal Spray
16%
Treatment-Resistant Depression
100%